UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 03/2016, Volume 387, Issue 10023, pp. 1075 - 1084
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Male | Treatment Outcome | Disease Progression | Dose-Response Relationship, Drug | Young Adult | Adolescent | Adult | Female | Aged | Multiple Sclerosis, Chronic Progressive - drug therapy | Immunosuppressive Agents - administration & dosage | Fingolimod Hydrochloride - administration & dosage | Phosphates | Clinical trials | Medical colleges | Multiple sclerosis | Research institutes | Sphingosine | Studies | Drug therapy | Neurodegeneration | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 3, pp. 209 - 220
CD20 | MULTICENTER TRIAL | DEMYELINATION | DOUBLE-BLIND | CANCER-RISK | ANTIBODY | PATHOLOGY | DAMAGE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Brain - diagnostic imaging | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, CD20 | Double-Blind Method | Multiple Sclerosis, Chronic Progressive - immunology | T-Lymphocytes | Humans | Middle Aged | Male | Disease Progression | Young Adult | Magnetic Resonance Imaging | B-Lymphocytes - immunology | Adolescent | Infusions, Intravenous - adverse effects | Intention to Treat Analysis | Lymphocyte Count | Adult | Female | Multiple Sclerosis, Chronic Progressive - drug therapy | Neuroimaging | Multiple sclerosis | Intravenous administration | Pathogenesis | Clinical trials | Patients | Placebo effect | Magnetic resonance imaging | Lymphocytes B | Lymphocytes | Immunotherapy | Immunopathogenesis | Monoclonal antibodies | CD20 antigen | Respiratory tract diseases | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
Lancet neurology, ISSN 1474-4422, 2014, Volume 13, Issue 3, pp. 247 - 256
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Double-Blind Method | Administration, Oral | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Multiple Sclerosis, Relapsing-Remitting - diagnosis | Toluidines - administration & dosage | Multiple Sclerosis, Relapsing-Remitting - epidemiology | Adult | Female | Crotonates - administration & dosage | Clinical trials | Medical colleges | Multiple sclerosis | Care and treatment | Voice recognition | Patient safety | Disease | Drug therapy | Drug dosages | Index Medicus | Medicin och hälsovetenskap
Journal Article
Lancet neurology, ISSN 1474-4422, 2012, Volume 11, Issue 5, pp. 467 - 476
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disability Evaluation | Retina - drug effects | Multiple Sclerosis - diagnosis | Tomography, Optical Coherence | Humans | Disease Progression | Randomized Controlled Trials as Topic | Brain - drug effects | Magnetic Resonance Imaging | Activities of Daily Living - classification | Neurologic Examination | Biomarkers | Brain - pathology | Retina - pathology | Multiple Sclerosis - drug therapy | Measurement | Clinical trials | Multiple sclerosis | Data processing | biomarkers | Quality of life | Index Medicus
Journal Article
Multiple sclerosis, ISSN 1352-4585, 10/2017, Volume 23, Issue 12, pp. 1636 - 1641
progression | phenotypes | outcomes research | primary progressive multiple sclerosis | efficacy | Trial design | Neuroprotective Agents - therapeutic use | Clinical Trials as Topic | Multiple Sclerosis, Chronic Progressive - drug therapy | Humans | Patient Selection | Clinical trials | Neuroprotection | Multiple sclerosis | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2014, Volume 13, Issue 10, pp. 977 - 986
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Male | Alanine Transaminase - blood | Toluidines - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Endpoint Determination | Adult | Female | Crotonates - administration & dosage | Toluidines - therapeutic use | Double-Blind Method | Immunologic Factors - administration & dosage | Proportional Hazards Models | Treatment Outcome | Toluidines - adverse effects | Magnetic Resonance Imaging | Crotonates - therapeutic use | Aspartate Aminotransferases - blood | Adolescent | Immunologic Factors - adverse effects | Crotonates - adverse effects | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Clinical trials | Medical colleges | Multiple sclerosis | Care and treatment | Spinal cord | Disease | Drug therapy | Patients | Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 3, pp. 221 - 234
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Recurrence | Brain - diagnostic imaging | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, CD20 | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Male | Disease Progression | Interferon-beta - therapeutic use | Magnetic Resonance Imaging | B-Lymphocytes - immunology | Interferon-beta - adverse effects | Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging | Infusions, Intravenous - adverse effects | Adult | Female | Immunologic Factors - adverse effects | Immunologic Factors - therapeutic use | Multiple sclerosis | Intravenous administration | Lymphocytes B | Lymphocytes | β-Interferon | Immunotherapy | Clinical trials | Monoclonal antibodies | CD20 antigen | Gadolinium | Cognition | Interferon | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Annals of neurology, ISSN 0364-5134, 2011, Volume 69, Issue 2, pp. 292 - 302
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Magnetic Resonance Imaging | Multiple Sclerosis - diagnosis | Early Diagnosis | Humans | Sensitivity and Specificity | Revisions | Multiple sclerosis | Older people | Index Medicus | Rapid Communication | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article